The purpose of this study was to investigate the host response to systemically administered lipid nanoparticles (NPs) encapsulating pDNA in the spleen using a DNA microarray. As a model for NPs, we used a Multifunctional envelope-type nano device (MEND). Microarray analysis revealed that 1581 of the differentially expressed genes could be identified by PEG-unmodified NP using a 3-fold change relative to the control. As the result of PEGylation, the NP treatment resulted in the reduction in the expression of most of the genes. However, the expression of type I interferon (IFN) was specifically increased by PEGylation. Based on the microarray and a pathway analysis, we hypothesize that PEGylation inhibited the endosomal escape of NP, and extended the interaction of TLR9 with CpG-DNA accompanied by the production of type I IFN. This hypothesis was tested by introducing a pH-sensitive fusogenic peptide, GALA, which enhances the endosomal escape of PEGylated NP. As expected, type I IFN was reduced and IL-6 remained at the baseline. These findings indicate that a carrier design based on microarray analysis and the manipulation of intracellular trafficking constitutes a rational strategy for reducing the host immune response to NPs.
Introduction
The success of clinical gene therapy greatly depends on the development not only of efficient but also safe gene delivery systems [1] . Because of the ease of large-scale production and lack of a specific immune response unlike viral vectors, various types of non-viral gene delivery systems such as lipoplexes, polyplexes, and micelles have been developed, in attempts to improve the efficiency of in vivo gene expression [2] [3] [4] . However, innate immune responses are induced by the systemic administration of a lipoplex [5] . Unmethylated CpG motifs of plasmid DNA in a lipoplex have been reported to stimulate the innate immune response by interacting with host Toll-like receptor-9 (TLR9), expressed in endosomes, and to trigger the release of inflammatory cytokines, such as tumor necrosis factor- (TNF-), interleukin-6 (IL-6) and IL-12 and type I interferon (IFN) [6] . It was reported that a lipoplex containing either methylated CpG or non-CpG pDNA reduced cytokine production, but the reduction was not complete [5, 7, 8] . Furthermore, cytokine production was not completely abolished in TLR9 -/-mice after an i.v. administration of a lipoplex or in primary cultured macrophages from TLR9 -/-mice after lipoplex treatment [7, 9] . DNA-dependent activator of IFN-regulatory factor (DAI) has been identified as a cytosolic DNA sensor [10] . DAI, also known as Z-DNA binding protein-1 (ZBP1), recognizes dsDNA in a CpG-independent manner, which causes an TLR9-independent innate immune response [11] . These findings suggest that the immune reaction to a lipoplex is more complicated than previously thought. This appears to be true for viral vectors [12] as well, and an understanding of host responses to the systemic administration of a lipoplex is necessary for the successful and efficacious development of in vivo gene delivery systems.
However, examining the production of certain types of cytokines after i.v. administration is not sufficient to guarantee the safety of a gene delivery system.
To address and solve this issue, gene expression profiling represents a promising approaches to understanding the underlying mechanism of host responses [13] [14] [15] [16] [17] [18] [19] . Kay and co-workers reported that a DNA microarray-based comparison of the host response to adenoviral (Ad) and adeno-associated viral (AAV) vectors revealed that the host recognition of capsid and DNA of AAV is different from that of Ad [13] . This approach has been also applied to non-viral vectors in the form of toxicogenomics studies [16] [17] [18] [19] . In the case of a polypropylenimine dendrimer based DNA complex, a microarray analysis revealed that gene expression in culture cells was altered by the generation of the dendrimer, and was dependent on the cell lines [16] . However, the response of a host to a systemically administrated non-viral gene vector has not been examined using this approach.
We recently developed a novel lipid nanoparticle (NP), a multifunctional envelope-type nano device (MEND), in which pDNA is condensed with a polycation, followed by encapsulation with a lipid envelope [20] . In the present study, an analysis of splenic expression profiles in mice was conducted after the intravenous injection of MENDs as an NP model, using a whole-genome DNA microarray.
Since the spleen is the largest secondary lymphoid organ and contains tissue macrophages that are associated with an immune response after an intravenous injection of a lipoplex [21] . It was hypothesized that modification with PEG would confer biocompatibility for non-viral vectors, resulting in an improved safety [22] . It would permit us to predict whether PEGylation would change the gene expression profile by NP administration for the better. However, since only a few studies of the effect of PEGylation on host response have appeared, detailed information on the influence of PEGylation is not available. Therefore, we attempted to elucidate the effect of the PEGylation of NP (PEG-NP) on the host response.
Results

Characterization of NPs
The average diameter and -potential of the condensed pDNA/PEI complex particles were approximately 80 nm and -50 mV, respectively. The average diameters and -potentials of the prepared NPs are summarized in Table 1 . The PEG-unmodified NP (NP) was around 200 nm in diameter, and was highly positively charged due to the presence of a cationic lipid. PEG modification (PEG-NP) reduced the diameter of the NP and the positive charge was decreased, compared to an unmodified NP, as the result of the formation of a stable lamellar structure with a larger curvature and masking of the surface of the lipid envelope by the aqueous layer of the PEG moiety [23] . Modification of PEG-NP with chol-GALA (GALA-NP) slightly reduced the -potential of the NP since GALA contains negatively charged glutamic acid residues, but it had no influence on the diameter.
Microarray data analysis
To understand what occurs in a host following the systemic administration of an NP and a PEG-NP, splenic gene expression profiles in mice were generated using whole genome oligonucleotide microarrays. The spleen is the largest secondary lymphoid organ and is associated with the immune response [21] . Mice were injected via the tail vein with Hepes-buffered glucose (HBG), NP or PEG-NP. After 2 hr, the spleen was collected and RNA prepared from the tissues, microarrays were then hybridized, as described in the Materials and Methods section. Using a 3-fold change relative to the HBG treatment as a criterion for differential expression, 1581 genes were extracted from the administration of NP. A clustergram of these 1581 genes is shown in Figure 1 . The down-regulated 402 genes resulting from the NP treatment, compared to HBG were classified in Cluster 1, and the other 1179 genes, which were up-regulated by the NP treatment, were classified into Clusters 2 to 5.
In Clusters 1, 3 and 5 (55.8%), the variation in gene expression as the result of the PEG-NP treatment were reduced compared to the corresponding value for NP, suggesting that PEGylation reduces the biological stimulation of NP after systemic administration. On the other hand, the gene expression in Cluster 2 showed subtle alterations between NP and PEG-NP (42.7%). PEG-NP unexpectedly caused an increase in gene expression compared to NP, as shown in Cluster 4 (1.5%).
Gene Ontology (GO) analysis is used to identify the molecular pathways and describe the biological processes of the transcript profiling data. Based on the GO analysis, the GO terms of "Biological process" that were significantly overrepresented in each Cluster are shown in Table 2 . The GO terms of the down-regulated genes are related to cell division such as "cytokinesis", "mitosis", "M phase of mitotic cell cycle", differentiation and metabolism. On the other hand, the majority of GO terms for the up-regulated genes in Clusters 2 to 5 are mainly associated with "immune response", "response to biotic stimulus", "defense response" and related processes, which are generally associated with the immune system. These observations indicate that the characteristics of the up-regulated genes and down-regulated genes resulting from the NPs treatment were completely different.
We further listed the top 25 genes in order of greatly altered expression level by the NP treatment compared with HBG in each Cluster, as shown in Table 3 . The ratios of the gene expression level of PEG-NP/NP in Clusters 1, 3 and 5 were improved, and the ratios in Cluster 2 were comparable.
However, the ratios for PEG-NP/NP in Cluster 4 were greatly enhanced. In Cluster 3, inflammatory cytokines such as IL-6 and IFN- are ranked higher with significantly lower levels of expression in the PEG-NP treatment compared to NP. As shown in Table 3 , IFN- subtypes and IFN-, classified as type I IFN, are specifically located in Cluster 4.
Quantification of mRNA level in spleen and cytokine level in serum
To verify that mRNA levels are elevated in the spleen, the mRNA expression of IL-6, CD14, located in Cluster 3, and IFN- and IFN-, located in Cluster 4, the genes were further evaluated by quantitative RT-PCR. As shown in Figure 2 , the semiquantitative RT-PCR results were in good agreement with the expression information from the microarray analysis, confirming that these genes are actually up-regulated after NP or PEG-NP administration. We next assessed the levels of IL-6 and IFN- in serum at 2 and 6 hr after an i.v. injection of NP and PEG-NP. As shown in Figure  3a , NP induced the production of IL-6, and PEGylation markedly reduced the serum levels of IL-6.
On the other hand, the serum level of IFN- in the case of PEG-NP was equal or greater than that for NP. These observations were correlated with the amount of mRNA in the spleen, as evidenced by microarray analysis and quantitative PCR ( Figure 2 ).
Pathway analysis and the effect of the acceleration of endosomal escape of PEGylated NP by GALA on type I IFN production
Based on the microarray analysis, PEGylation generally reduced the biological reaction to systemically administered NP. However, contrary to our expectations, PEGylation stimulated the production of type I IFN. To identify the mechanism underlying this, we performed a pathway analysis. According to the GO analysis and a subsequent quantitative determination of mRNA in the spleen, immune stimulation constituted a major biological reaction in the host after the systemic administration of NP. Since members of the TLR family are essential components in the CpG-mediated immune response, we focused on TLR pathway signaling using the Kyoto Encyclopedia of Genes and Genomes (KEGG) data base. As shown in Figure 4 , IL-6, IL-1 and CD14, located in Cluster 3 (red) and IFN- and IFN- located in Cluster 4 (blue) fall into Toll-like receptor signaling pathway.
As described above, PEGylation confers biocompatibility and safety for NPs. On the other hand, it was reported that the modification of NP with PEG crucially inhibits the endosomal escape of NP [24, 25] , resulting in a reduced activity of the cargo. We assumed that endosomal trapping triggered the excessive interaction of the pDNA encapsulated in PEG-NP with TLR9 following destabilization and digestion of the PEG-NP in endosomes/lysosomes, which resulted in an enhanced type I IFN production. We previously demonstrated that a pH-sensitive fusogenic peptide, GALA promoted the endosomal escape of PEGylated NP, which resulted in enhanced gene expression and silencing activity [26] [27] [28] [29] . To test the assumption, we examined the effect of the GALA modification of PEG-NP (GALA-NP) on the immune response. The physical properties of the prepared GALA-NP were nearly the same as those for PEG-NP (Table 1 ). As shown in Figure5, GALA modification successfully diminished serum IFN-levels and IL-6 remained at a low level. The gene expression of IFN-in the spleen was also reduced by GALA modification.
Discussion
In the present study, we applied a microarray analysis to understand the host response to pDNA encapsulated in lipid nanoparticles (NPs). For the microarray analysis, we used a MEND, in which pDNA is condensed with PEI, followed by encapsulation with a lipid envelope consisting of DOTAP, DOPE and cholesterol. The systemic administration of the PEI/pDNA complex alone induced severe hepatotoxicity, but the innate immune response was negligible, unlike NPs ( Figure S1 ). These findings suggest that pDNA/PEI complex was successfully encapsulated by the lipid envelope of the MEND. These findings were also consistent with previous findings reported by Kawakami The microarray analysis showed that, after the systemic administration of NPs, the up-regulated genes in the spleen were mainly related to the immune system and the down-regulated genes were associated with mitosis and differentiation, as shown in Table 2 . These findings suggest that the characteristics between up-and down-regulated genes are completely different, presumably because the innate up-regulation of a gene related to immune system might turn out to down-regulate genes related to the maintenance of cell function such as cytokinesis, mitosis and cell differentiation. As we assumed, the variation in gene expression including IL-6 and IFN-in Clusters 1, 3 and 5 (55.8%) showed a tendency for improvement ( Figure 1 and 2). Serum inflammatory cytokines such as IL-6, TNF- and IFN- were significantly decreased as the result of PEGylation (Figure 3 and Figure S1 ). Therefore, PEGylation appears to contribute to the prevention of inflammatory cytokine production. However, the variation of expression in Cluster 2 (42.7%) was equivalent to the level of NP ( Figure 1 ). Unexpectedly, the expression of type I IFN in the spleen was conversely aggravated by PEGylation (Cluster 4; 1.5%)( Figure 1 and 2). As shown in Figure 3 , the serum level of IFN- in PEG-NP was equal to or greater than that for NP, in good agreement with the mRNA levels in the spleen. These results suggest that even though PEG is a well known biocompatible macromolecule, PEGylation is not an adequate solution to averting a host response to NPs.
The microarray analysis indicated that PEGylation altered the production of inflammatory cytokine such as IL-6 (better) and type I IFN such as IFN- (unchanged or worse) in a different pattern. The question arises as to the cause of the production of inflammatory cytokines and type I IFN by NP and PEG-NP. PEG modification under these conditions did not alter the splenic accumulation of NP after systemic administration ( Figure S2 ). Therefore, the change in cytokine production might be caused after NPs that had arrived in the spleen. The innate immune response to a lipoplex is partially, but not entirely, dependent on the CpG motif in pDNA via TLR9, which induces the production of type I IFN and inflammatory cytokines [6] . The plasmid DNA used in the present study contains 425 CpG motifs.
Hartman et al. previously reported that a pathway analysis following a microarray of Ad revealed that the Myeloid differentiation primary response gene (88) (MyD88) in the TLR signaling pathway plays a major role in the immune response to Ad [14, 15] . To elucidate the underlying mechanisms of the response to NP and PEGylated NP, we then focused on the Toll-like receptor signaling pathway using the KEGG database. As a result of the pathway analysis, IL-6, IL-1, and CD14 in Cluster 3, and IFN- and - in Cluster 4 correspond to the Toll-like receptor signaling pathway ( Figure 4 ).
CD14 is a glycosylphosphatidylinositol-anchored cell surface protein that is expressed by phagocytic cells [32] . The recognition of Lipopolysaccharide (LPS) by cells is mediated by the LPS receptor complex, which consists of TLR4, MD2 and CD14 [6] . It was observed that CD14 expression by bone marrow granulocytes and odontoblasts was increased by treatment with an agonist for TLR4, such as LPS [33, 34] . It was reported that diC14-amidine, a cationic lipid, is assumed to be an agonist for TLR4 due to the association of the acyl chains of diC14-amidine with the hydrophobic pocket in MD-2 [35] . Empty liposomes using the same lipid component in the envelope of NP showed neither inflammatory cytokine nor type I IFN production after systemic administration (data not shown).
Therefore, it is very unlikely that the lipid components used in the present study have the potential to function as a TLR4 agonist. However, since CD14 expression was significantly altered, an NP that included pDNA would not be irrelevant to a TLR4 mediated immune response. Kedmi et al.
recently reported that the immune activation of DOTAP based cationic lipid nanoparticles containing siRNA might occur via TLR4, which provides support for our prediction [36] .
PEGylation decreased the expression of CD14 as shown in Figure 2b , presumably because the cationic charge on the surface of the lipid envelope was masked by the PEG layer, which reduced the interaction of NP with biological milieu such as cellular membrane components. On the other hand, as describe above, PEGylation interrupts the intracellular trafficking of nanocarriers, especially in the case of endosomal escape [24, 25] . It is quite likely that the exposure time of pDNA to TLR9 in endosomes/lysosomes is prolonged due to the trapping of PEG-NP, which would lead to excess stimulation of TLR9, followed by an enhanced expression of IFN- and -. The time difference in the production of IL-6 and IFN- provides support for our prediction. Inflammatory cytokines such as IL-6 and TNF- showed a peak response at 2 hr after i.v. administration, and the production dropped rapidly by 6 hr because the interaction of NPs with the cell surface had already occurred, which was followed by the immediate uptake of NPs via endocytosis. Although the initial production of IFN- was slower than that of IL-6, the serum level of IFN- increased over the 6 hr period after the i.v. injection of PEG-NP due to the prolonged interaction of CpG DNA with TLR9 in endosomes.
Based on our hypothesis, we examined the effect of accelerating the endosomal escape of PEG-NP with GALA on the type I IFN production. We previously reported on the successful delivery of either an encapsulated aqueous phase marker, pDNA or siRNA into the cytosol by introducing GALA on the lipid envelope [26-28,37]. The acceleration in the endosomal escape of NP by GALA almost diminished IFN- production, and IL-6 remained at low levels ( Figure 5 ). The amount of GALA-NP in the spleen was comparable to that for NP and PEG-NP ( Figure S2 ). As an alternate to the use of GALA, PEG detached systems which have the ability to promote the endosomal escape of NPs, are considered to be another potential strategy for reducing type I IFN production in response to intracellular environments with a low pH in endosomes/lysosomes, reducing environment generated by small thiolytical molecules, e.g. glutathione, and enzymes such as cathepsin B [38-41].
As anther type of DNA sensor, it was reported that DAI (ZBP1) has a role as a cytosolic dsDNA receptor in a CpG-independent manner [9] . In the present study, the expression of Zbp1 located in Cluster 2 was increased 10-fold by both NP and PEG-NP compared to the control. Although the amount of cytosolic pDNA escaping from endosomes would be increased by presence of GALA, no further immune response occurred. Therefore, the contribution of DAI in the immune response to NP would be miner, and GALA modification could reduce type I IFN production presumably because of the acceleration of endosomal escape. These results lead us to predict that the immune stimulation of NP mediated by TLR9 mainly results in the production of type I IFN in a CpG-dependent manner, whereas that mediated by TLR4 induces inflammatory cytokines in a CpG-independent manner. Although TLR 1/2 and 6 on the cell surface are also linked to inflammatory cytokine production, the involvement with TLR1/2 and 6 are presently unclear. Of course, further studies will be required to completely understand the mechanisms and pathways for the immune response.
In summary, a microarray based analysis was performed, to explore the mechanism of host responses to systemically administrated NPs. As expected, PEGylation partially reduced the host response to NP. However, PEGylation also stimulated the response of type I IFN to NP. The pathway and mechanism analysis yielded insights into the causes of cytokine production and a strategy for the design of a carrier that can escape specific immune activation. The present study provides the first rational strategy for reducing immunological stimulation based on the genome wide microarray analysis of systemically administrated non-viral lipid nanoparticles. Microarray expression data were obtained using the Agilent Feature Extraction software (Version A.6.1.1).
Materials and Methods
Materials
Data analysis
Microarray data were analyzed using GeneSpring software version 7.3 (Agilent, Foster City, CA, USA). Genes were regarded as up-regulated when they had a ratio of ≥ 3 and as down-regulated when they had a ratio of ≤ 0.34 in the administration of NP compared with HBG treatment. To understand the differential gene expression pattern, a hierarchical clustering analysis was performed using a Pearson Correlation and an average linkage clustering algorithm. The Gene Ontology (GO) analysis was performed to assign biological meaning to the subset of gene clusters.
Overrepresentation of genes with altered expression in the NP treatment compared with the HBG treatment within specific GO categories was determined using Fisher's exact probability test.
Pathway analysis of Toll-like receptor signaling pathway was performed by using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway map
Statistical analysis
Comparisons between multiple treatments were made using one-way analysis of variance (ANOVA), followed by the Bonferroni test. Pair-wise comparisons between treatments were made using a student's t-test. A P-value of < 0.05 was considered significant. Figure S1 . Serum levels of cytokines and ALT. Tables Table 1 Physical The data are expressed as the mean ± SD. (n=3). "Genes in List in Category" represent the number of genes that were classified as the statistically overrepresented GO term. Therefore, the different pattern of cytokine and interferon production presumably resulted from the alternation of intracellular fate of NP by modification of PEG and GALA.
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